Logo image of BMEZ

BLACKROCK HLTH SCI TRM TR II (BMEZ) Stock Price, Quote, News and Overview

NYSE:BMEZ - New York Stock Exchange, Inc. - US09260E1055 - Currency: USD

15.84  -0.24 (-1.49%)

Fundamental Rating

3

Overall BMEZ gets a fundamental rating of 3 out of 10. We evaluated BMEZ against 0 industry peers in the Unkown industry. While BMEZ seems to be doing ok healthwise, there are quite some concerns on its profitability. BMEZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BMEZ had positive earnings in the past year.
In the past year BMEZ had a positive cash flow from operations.
BMEZ Yearly Net Income VS EBIT VS OCF VS FCFBMEZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1B -1B -2B

1.2 Ratios

Industry RankSector Rank
ROA 9.02%
ROE 9.45%
ROIC N/A
ROA(3y)-12.9%
ROA(5y)N/A
ROE(3y)-13.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMEZ Yearly ROA, ROE, ROICBMEZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 20 -20

1.3 Margins

BMEZ's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for BMEZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 1956.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-69.58%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BMEZ Yearly Profit, Operating, Gross MarginsBMEZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5K -5K 10K 15K

More info and screens

5

2. Health

2.1 Basic Checks

BMEZ has less shares outstanding than it did 1 year ago.
The debt/assets ratio for BMEZ is higher compared to a year ago.
BMEZ Yearly Shares OutstandingBMEZ Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
BMEZ Yearly Total Debt VS Total AssetsBMEZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

BMEZ has an Altman-Z score of 10.42. This indicates that BMEZ is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for BMEZ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.42
ROIC/WACCN/A
WACCN/A
BMEZ Yearly LT Debt VS Equity VS FCFBMEZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 1B -1B 2B -2B 3B

2.3 Liquidity

A Current Ratio of 0.48 indicates that BMEZ may have some problems paying its short term obligations.
BMEZ has a Quick Ratio of 0.48. This is a bad value and indicates that BMEZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.48
BMEZ Yearly Current Assets VS Current LiabilitesBMEZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 110.39% over the past year.
The earnings per share for BMEZ have been decreasing by -61.65% on average. This is quite bad
Looking at the last year, BMEZ shows a very strong growth in Revenue. The Revenue has grown by 43.05%.
Measured over the past years, BMEZ shows a very strong growth in Revenue. The Revenue has been growing by 23.73% on average per year.
EPS 1Y (TTM)110.39%
EPS 3Y-61.65%
EPS 5YN/A
EPS Q2Q%-174.49%
Revenue 1Y (TTM)43.05%
Revenue growth 3Y23.73%
Revenue growth 5YN/A
Sales Q2Q%58.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMEZ Yearly Revenue VS EstimatesBMEZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2M 4M 6M 8M 10M
BMEZ Yearly EPS VS EstimatesBMEZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 25.14, which means the current valuation is very expensive for BMEZ.
BMEZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.63.
Industry RankSector Rank
PE 25.14
Fwd PE N/A
BMEZ Price Earnings VS Forward Price EarningsBMEZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.62
EV/EBITDA N/A
BMEZ Per share dataBMEZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.21%, BMEZ is a good candidate for dividend investing.
BMEZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 11.21%

5.2 History

BMEZ has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BMEZ Yearly Dividends per shareBMEZ Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

98.89% of the earnings are spent on dividend by BMEZ. This is not a sustainable payout ratio.
DP98.89%
EPS Next 2YN/A
EPS Next 3YN/A
BMEZ Yearly Income VS Free CF VS DividendBMEZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 1B -1B -2B
BMEZ Dividend Payout.BMEZ Dividend Payout, showing the Payout Ratio.BMEZ Dividend Payout.PayoutRetained Earnings

More info and screens

BLACKROCK HLTH SCI TRM TR II

NYSE:BMEZ (2/21/2025, 8:04:00 PM)

15.84

-0.24 (-1.49%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.7%
Inst Owner Change0.75%
Ins Owners0.02%
Ins Owner Change0%
Market Cap1.69B
Analysts0
Price TargetN/A
Short Float %0.13%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 11.21%
Yearly Dividend1.61
Dividend Growth(5Y)N/A
DP98.89%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-14 2025-02-14 (0.1773)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.14
Fwd PE N/A
P/S 169.73
P/FCF 6.62
P/OCF 6.62
P/B 0.82
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)0.63
EY3.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.39
FCFY15.11%
OCF(TTM)2.39
OCFY15.11%
SpS0.09
BVpS19.33
TBVpS19.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.02%
ROE 9.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1956.24%
GM N/A
FCFM 2564.39%
ROA(3y)-12.9%
ROA(5y)N/A
ROE(3y)-13.06%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-69.58%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 131.09%
Current Ratio 0.48
Quick Ratio 0.48
Altman-Z 10.42
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)110.39%
EPS 3Y-61.65%
EPS 5YN/A
EPS Q2Q%-174.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.05%
Revenue growth 3Y23.73%
Revenue growth 5YN/A
Sales Q2Q%58.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y41.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.67%
OCF growth 3YN/A
OCF growth 5YN/A